About Hemodynamic Monitoring
Hemodynamic monitoring is a patient monitoring technique that involves the measurement of the blood pressure in the heart, vein, and arteries and oxygen levels. The type of hemodynamic monitoring depends on the medical situation of a person — critical condition or admitted in the ICU for a simple surgery. Physicians use advanced hemodynamic monitoring to measure the intravascular volume status and intake and output of oxygen in people who are in critical condition. They use basic hemodynamic monitoring to measure the heart rate and temperature and analyze the blood gas levels in people admitted in ICUs for simple surgeries.
Technavio’s analysts forecast the global hemodynamic monitoring devices market to grow at a CAGR of 6.44% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global hemodynamic monitoring devices market for 2016-2020.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Hemodynamic Monitoring Market 2016-2020
Technavio recognizes the following companies as the key players in the Global Hemodynamic Monitoring Market: Edwards Lifesciences Corp., ICU Medical Inc., LiDCO Ltd., and PULSION Medical Systems SE.
Other Prominent Vendors in the market are: Cheetah Medical, Deltex Medical Group, FUJIFILM SonoSite, GE Healthcare, Mindray, Nihon Kohden, NImedical, Noninvasive Medical Technologies, Osypka Medical, Philips Healthcare, Schwarzer Cardiotek, Tensys Medical, and Uscom.
Commenting on the report, an analyst from Technavio’s team said: “Funding from government sources and companies helps increase the sales of hemodynamic monitors. In the US, the NIH funds its Vascular Interventions/Innovations and Therapeutic Advances Program that is involved in accelerating the development of diagnostic and therapeutic modalities. The program helps develop various tests for the novel pulmonary arterial hypertension therapy by combining hemodynamic monitoring with advanced software and technology.”
According to the report, demand in disease treatment and critical care is one of the major factors driving the growth of this market globally. People of all ages, particularly infants, women, and older people are susceptible to various diseases. In infants, congenital heart disease is one of the major disorders. This is due to the occurrence of structural defects during the development of the heart in the fetal stage. Physicians use pulse oximetry to detect this disease in infants. The procedure involves the measurement of oxygen levels in the blood. Low oxygen levels in the blood of infants signify the presence of heart problems.
Further, the report states that risks associated with invasive hemodynamic monitoring have led to the decline in the use of associated devices, decreasing their market share.
Edwards Lifesciences Corp., ICU Medical Inc., LiDCO Ltd., PULSION Medical Systems SE, Cheetah Medical, Deltex Medical Group, FUJIFILM SonoSite, GE Healthcare, Mindray, Nihon Kohden, NImedical, Noninvasive Medical Technologies, Osypka Medical, Philips Healthcare, Schwarzer Cardiotek, Tensys Medical, Uscom.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook